Diagnostic testing for Prader-Willi syndrome and Angelman syndrome

A cost comparison

Kristin G. Monaghan, Anne Wiktor, Daniel L. Van Dyke

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Purpose: Considering cost as a factor, the authors evaluated three approaches to the diagnostic testing of Prader-Willi syndrome (PWS) and Angelman syndrome (AS). Methods: The approaches evaluated were (1) DNA methylation studies followed by fluorescence in situ hybridization (FISH) for any positive DNA result, (2) FISH analysis followed by DNA testing for any negative result, and (3) simultaneous DNA testing and FISH analysis. Results: Of 136 samples submitted for chromosome analysis and DNA methylation analysis for PWS or AS, 114 had a normal chromosome analysis and methylation studies, 9 were positive for AS, 3 were positive for PWS, and 7 had an abnormal chromosome analysis, but not deletion 15q11.2-q13, and normal methylation studies. On the basis of these results, the authors compared the cost of each testing strategy. Conclusion: DNA methylation studies followed by confirmation with FISH for any positive result yields a significant cost savings compared with the other approaches.

Original languageEnglish (US)
Pages (from-to)448-450
Number of pages3
JournalGenetics in Medicine
Volume4
Issue number6
DOIs
StatePublished - Nov 2002
Externally publishedYes

Fingerprint

Angelman Syndrome
Prader-Willi Syndrome
Fluorescence In Situ Hybridization
DNA Methylation
Costs and Cost Analysis
Chromosomes
Methylation
DNA
Cost Savings

Keywords

  • Angelman syndrome
  • Cost analysis
  • Prader-Willi syndrome

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Diagnostic testing for Prader-Willi syndrome and Angelman syndrome : A cost comparison. / Monaghan, Kristin G.; Wiktor, Anne; Van Dyke, Daniel L.

In: Genetics in Medicine, Vol. 4, No. 6, 11.2002, p. 448-450.

Research output: Contribution to journalArticle

Monaghan, Kristin G. ; Wiktor, Anne ; Van Dyke, Daniel L. / Diagnostic testing for Prader-Willi syndrome and Angelman syndrome : A cost comparison. In: Genetics in Medicine. 2002 ; Vol. 4, No. 6. pp. 448-450.
@article{5d1d82641b30480b90340d2046f2ae67,
title = "Diagnostic testing for Prader-Willi syndrome and Angelman syndrome: A cost comparison",
abstract = "Purpose: Considering cost as a factor, the authors evaluated three approaches to the diagnostic testing of Prader-Willi syndrome (PWS) and Angelman syndrome (AS). Methods: The approaches evaluated were (1) DNA methylation studies followed by fluorescence in situ hybridization (FISH) for any positive DNA result, (2) FISH analysis followed by DNA testing for any negative result, and (3) simultaneous DNA testing and FISH analysis. Results: Of 136 samples submitted for chromosome analysis and DNA methylation analysis for PWS or AS, 114 had a normal chromosome analysis and methylation studies, 9 were positive for AS, 3 were positive for PWS, and 7 had an abnormal chromosome analysis, but not deletion 15q11.2-q13, and normal methylation studies. On the basis of these results, the authors compared the cost of each testing strategy. Conclusion: DNA methylation studies followed by confirmation with FISH for any positive result yields a significant cost savings compared with the other approaches.",
keywords = "Angelman syndrome, Cost analysis, Prader-Willi syndrome",
author = "Monaghan, {Kristin G.} and Anne Wiktor and {Van Dyke}, {Daniel L.}",
year = "2002",
month = "11",
doi = "10.1097/00125817-200211000-00009",
language = "English (US)",
volume = "4",
pages = "448--450",
journal = "Genetics in Medicine",
issn = "1098-3600",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Diagnostic testing for Prader-Willi syndrome and Angelman syndrome

T2 - A cost comparison

AU - Monaghan, Kristin G.

AU - Wiktor, Anne

AU - Van Dyke, Daniel L.

PY - 2002/11

Y1 - 2002/11

N2 - Purpose: Considering cost as a factor, the authors evaluated three approaches to the diagnostic testing of Prader-Willi syndrome (PWS) and Angelman syndrome (AS). Methods: The approaches evaluated were (1) DNA methylation studies followed by fluorescence in situ hybridization (FISH) for any positive DNA result, (2) FISH analysis followed by DNA testing for any negative result, and (3) simultaneous DNA testing and FISH analysis. Results: Of 136 samples submitted for chromosome analysis and DNA methylation analysis for PWS or AS, 114 had a normal chromosome analysis and methylation studies, 9 were positive for AS, 3 were positive for PWS, and 7 had an abnormal chromosome analysis, but not deletion 15q11.2-q13, and normal methylation studies. On the basis of these results, the authors compared the cost of each testing strategy. Conclusion: DNA methylation studies followed by confirmation with FISH for any positive result yields a significant cost savings compared with the other approaches.

AB - Purpose: Considering cost as a factor, the authors evaluated three approaches to the diagnostic testing of Prader-Willi syndrome (PWS) and Angelman syndrome (AS). Methods: The approaches evaluated were (1) DNA methylation studies followed by fluorescence in situ hybridization (FISH) for any positive DNA result, (2) FISH analysis followed by DNA testing for any negative result, and (3) simultaneous DNA testing and FISH analysis. Results: Of 136 samples submitted for chromosome analysis and DNA methylation analysis for PWS or AS, 114 had a normal chromosome analysis and methylation studies, 9 were positive for AS, 3 were positive for PWS, and 7 had an abnormal chromosome analysis, but not deletion 15q11.2-q13, and normal methylation studies. On the basis of these results, the authors compared the cost of each testing strategy. Conclusion: DNA methylation studies followed by confirmation with FISH for any positive result yields a significant cost savings compared with the other approaches.

KW - Angelman syndrome

KW - Cost analysis

KW - Prader-Willi syndrome

UR - http://www.scopus.com/inward/record.url?scp=0038690664&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038690664&partnerID=8YFLogxK

U2 - 10.1097/00125817-200211000-00009

DO - 10.1097/00125817-200211000-00009

M3 - Article

VL - 4

SP - 448

EP - 450

JO - Genetics in Medicine

JF - Genetics in Medicine

SN - 1098-3600

IS - 6

ER -